Cash Flow Statement (TTM)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.
All numbers are times 1,000,000 except per share units.
|
2021 12-31 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Cash From Operating Activities | -191 | -239 | -259 | -280 | -324 | -368 | -363 | -358 | -243 | -128 |
| Change (%) | 25.28 | 8.59 | 7.91 | 15.71 | 13.57 | -1.27 | -1.29 | -32.13 | -47.34 | |
| % of Cash Flow | -39.32 | 720.87 | 169.05 | 102.25 | 107.56 | 111.98 | 125.71 | 143.79 | 619.42 | -75.04 |
| Cash From Investing Activities | -109 | 0 | -16 | -32 | -163 | -295 | -256 | -216 | -89 | 38 |
| Change (%) | -100.05 | -32,485.71 | 100.31 | 413.78 | 80.54 | -13.34 | -15.39 | -58.78 | -142.58 | |
| % of Cash Flow | -22.43 | -0.15 | 10.35 | 11.62 | 54.28 | 89.83 | 88.51 | 86.78 | 227.04 | 22.24 |
| Cash From Financing Activities | 793 | 179 | 100 | 21 | 176 | 331 | 329 | 327 | 293 | 259 |
| Change (%) | -77.38 | -44.25 | -79.36 | 752.04 | 88.26 | -0.62 | -0.63 | -10.40 | -11.61 | |
| % of Cash Flow | 163.63 | -541.70 | -65.22 | -7.54 | -58.44 | -100.85 | -113.96 | -131.23 | -746.28 | 151.76 |
| Cash Flow | 485 | -33 | -153 | -274 | -301 | -328 | -289 | -249 | -39 | 171 |
| Change (%) | -106.83 | 363.05 | 78.40 | 9.99 | 9.09 | -12.05 | -13.70 | -84.24 | -534.69 | |
| % of Cash Flow | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Source: Capital IQ
